| Test |
In Range |
Out Of Range |
Units |
Reference |
| Vitamin B12 |
|
2614 H |
pg/mL |
211 - 911 |
| |
| Sodium |
137 |
|
mmol/L |
136-145 |
| Potassium |
4.6 |
|
mmol/L |
3.5 - 5.1 |
| Chloride |
103 |
|
mmol/L |
98 - 107 |
| Bicarbonate |
28 |
|
mmol/L |
21 - 32 |
| Anion Gap |
6 |
|
mmol/L |
3 - 12 |
| Glucose |
97 |
|
mg/dL |
70 - 99 |
| BUN |
|
19 H |
mg/dL |
7 - 18.0 |
| Creatinine |
0.94 |
|
mg/dL |
0.60 - 1.10 |
| eGFR-Other |
80 |
|
See comment |
> 60 |
| |
Units: mL/min/1.73 m2 Estimated glomerular filtration rate values are calculated using the CKD-EPI equation. |
| Calcium |
9.2 |
|
mg/dL |
8.5 - 10.1 |
| Total Protein |
6.8 |
|
g/dL |
6.2 - 8.5 |
| Albumin |
3.9 |
|
g/dL |
3.4 - 5.0 |
| Bilirubin, Total |
0.4 |
|
mg/dL |
< 1.1 |
| Alkaline Phosphatase |
97 |
|
U/L |
50 - 136 |
| AST |
|
L 11 |
U/L |
15 - 37 |
| ALT |
18 |
|
U/L |
0 - 60 |
| |
| Iron/Iron Binding |
|
|
|
|
| Iron |
77 |
|
ug/dL |
35 - 150 |
| Iron Binding |
337 |
|
ug/dL |
250 - 450 |
| Iron Saturation |
23 |
|
% |
20 - 50 |
| |
| Hemoglobin Alc |
|
L 4.7 |
% |
4.8 - 5.6 |
| Average Glucose |
88 |
|
mg/dL |
|
| |
| TSH |
1.86 |
|
uIU/mL |
0.40 - 4.50 |
| |
| VitD, 25-Hydroxy Total |
36 |
|
ng/mL |
30 - 100 |
| |
This Total 25-OHD assay measures the sum of 25-hydroxy (D2 and D3) Vitamin D matabolites. Therapy indications are based on Total 25-OHD, as follows: Deficiency: Less than 20 ng/mL, Insufficiency: 20 - 29 ng/mL, Sufficiewncy Level: 30 - 100 ng/mL |
| |
| CBC w Auyto Diff |
|
|
|
|
| WBC Count |
4.7 |
|
K/uL |
4.0 - 11.0 |
| RBC Count |
|
L 3.81 |
M/uL |
4.40 - 6.00 |
| Hemoglobin |
|
L 12.4 |
g/dL |
13.5 - 18.0 |
| Hematocrit |
|
L 37.5 |
% |
40.0 - 52.0 |
| MCV |
98 |
|
fL |
80 - 100 |
| MCH |
32.5 |
|
pg |
27.0 - 33.0 |
| MCHC |
33.1 |
|
g/dL |
31.0 - 36.0 |
| RDW |
13.1 |
|
% |
< 16.4 |
| Platelet Count |
229 |
|
K/uL |
150 - 400 |
| Diff Type Automated |
|
|
|
|
| Neutrophil |
65 |
|
% |
49.0 - 74.0 |
| Lymphocytes |
|
L 22 |
% |
26.0 - 46.0 |
| Monocyte |
11 |
|
% |
2.0 - 12.0 |
| Eosinophil |
2 |
|
% |
0.0 - 5.0 |
| Basophil |
0 |
|
% |
0.0 - 2.0 |
| Abs. Neutrophil |
3.0 |
|
K/uL |
2.0 - 8.0 |
| Abs. Lymphocyte |
1.0 |
|
K/uL |
1.0 - 5.1 |
| Abs. Monocyte |
0.5 |
|
K/uL |
0.0 - 0.8 |
| Abs. Eosinophil |
0.1 |
|
K/uL |
0.0 - 0.5 |
| Abs. Basophil |
0.0 |
|
K/uL |
0.0 - 0.2 |
| |
| Protime |
| Protime, Patient |
13.2 |
|
sec |
12.1 - 15.0 |
| INR |
1.0 |
|
See comment |
0.9 - 1.1 |
| |
INR Therapeutic Ranges for Coumadin Anticoagulation Therapies are as follows: Usual prophylaxis and treatment: 2.0 - 3.0 (Venous thrombosis, pulmonary embolism, tissue heart valves, atrial fib, M.I.), Mechanical prosthetic values: 2.5 - 3.5 |
| |
| PTT, Patient |
26.0 |
|
sec |
23.2 - 36.6 |
| Magnesium, RBC |
4.2 |
|
mg/dL |
4.0 - 6.4 |